View Article

Abstract

Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains one of the leading infectious diseases worldwide and continues to pose a significant public health challenge due to the emergence of drug-resistant strains and limitations associated with current treatment regimens. The search for novel therapeutic agents from natural sources has gained considerable attention in recent years. Pontederia crassipes (water hyacinth), an aquatic plant belonging to the family Pontederiaceae, has attracted scientific interest because of its rich phytochemical composition and diverse biological activities. Although commonly regarded as an invasive aquatic weed, water hyacinth contains various bioactive constituents, including alkaloids, flavonoids, phenolic compounds, terpenoids, tannins, and other secondary metabolites that exhibit antimicrobial, antioxidant, and anti-inflammatory properties. This article provides an overview of compounds for the development of novel therapeutic strategies against tuberculosis and supports further investigations through phytochemical screening, biological evaluation, the botanical characteristics, geographical distribution, phytochemical constituents, and pharmacological potential of P. crassipes, with particular emphasis on its possible role as a source of anti-tubercular agents. The study highlights the importance of exploring plant-derived bioactive and molecular studies.

Keywords

Pontederia crassipes, natural products, Tuberculosis, Phytochemicals. Anti-Tubercular activity, Molecular docking

Introduction

× Popup Image

Water Hyacinth

Pontederia Crassipes (Water Hyacinth) Pontederia crassipes, commonly referred to as water hyacinth, is an aquatic plant with floating nature. It is one of the most rapidly growing plants in the globe and commonly found in tropical and subtropical countries3.They are found commonly in freshwater bodies like ponds, lakes, rivers, and canals. This plant is a native of Amazon basin of South America and extended in different regions of the world due to accelerated growth and adaptability. Water hyacinth is commonly identified with thick, glossy leaves, and swollen petioles on the with charming violet or lavender colour flowers4. Though it is regarded as an invasive, and nuisance plant due to its capability to cover large water areas, and trouble to aquatic biota but gained interest for potential beneficial uses. In recent years, water hyacinth has been investigated for diverse applications including wastewater treatment, biofuel production, and medicinal purposes5. Water hyacinth is known to contain wide spectrum of phytochemicals like alkaloids, flavonoids, phenolic compounds, terpenoids, which are responsible for the biological properties6. Studies show that water hyacinth display antimicrobial, antioxidant and anti-inflammatory properties and suggest thatplant may offer potential source of bioactive molecules for novel therapeutic agents7.

Taxonomical Classification

  • Kingdom: Plantae
  • Division: Angiosperms
  • Class: Monocotyledonae
  • Order: Commelinales
  • Family: Pontederiaceae
  • Genus: Pontederia
  • Species: Pontederia crassipes

Botanical Description

Water hyacinth is a floating aquatic plant with fully developed fibrous root system hanging freely in water. Its roots are dark, feathery and which helps in the nutrient absorption. Plant possesses short stems and formed dense mats on water surface. The leaves of plant are thick, broad, and glossy with characteristic swollen petioles which helps the plant to float. Leaf blades are oval to round shaped and in rosette pattern. The flower isattractive, with usually lavender to violet in color, with yellow spot in upper petal. They are arranged in spikelike aggregation and they are considered to be one of the most special characteristics of plant8

     

 

Figure 1.Pontederia crassipes (water hyacinth) growing in its natural aquatic habitat showing the characteristic vegetative and flowering morphology.

Geography Distribution

Habitat- Water hyacinth is native to Amazon basin of South America but presently it was extensively spread in tropical and subtropical part of world. It is now found countries all over the world in various regions like Asia, Africa, and North America. In India, Water hyacinth is commonly observed in freshwater bodies such as ponds, lakes, rivers and irrigation canals. It develops well in warm climate with high nutrient availability in water. It prefers stagnant and slowmoving water and can rapidly increase in volume if proper condition exist, often form dense mats covering surface of water which affect the aquatic life and water quality. In many places, it is seen as invasive in bodies of water.9

Tuberculosis

Tuberculosis (TB) is a chronic and granulomatous infectious disease which is caused by the bacillus called Mycobacterium tuberculosis. This infection mainly affects the lungs called pulmonary tuberculosis, but it can also affect extrapulmonary areas such as lymph nodes, pleura, bones, joints, kidneys, meninges etc10. Tuberculosis is one of the most important infectious diseases in the world. Tuberculosis exists in two forms: latent and active. In latent tuberculosis infection (LTBI), people stay a bacteria in the body called Mycobacterium tuberculosis, but do not show any symptoms and do not spread the disease. However, bacteria can become inactive for many years in the body and only become active later, when their immune system is weak or fails. On the other hand, active tuberculosis shows clear and clear symptoms and can spread to other people, especially if it is pulmonary11.

The pathological feature of tuberculosis is the formation of a granuloma, an organized aggregate of immune cells that develops to contain and control infection caused by Mycobacterium tuberculosis. Tuberculous granulomas are composed of various cell types, including macrophages, epithelioid cells, multinucleated giant cells, and lymphocytes12. A characteristic feature of these granulomas is caseous necrosis, in which the central region undergoes tissue destruction and develops a soft, cheese-like appearance13. Although granuloma formation plays a protective role by restricting bacterial spread, it also provides a microenvironment that allows M. tuberculosis to persist in a dormant state, contributing to latent infection and the potential for disease reactivation14.

Tuberculosis is an airborne infectious disease that is primarily transmitted through the inhalation of aerosolized droplets containing Mycobacterium tuberculosis. Transmission occurs when individuals with active pulmonary tuberculosis cough, sneeze, speak, or sing, releasing infectious particles into the air that can remain suspended for prolonged periods and be inhaled by susceptible individuals15. Exposure to even a small number of bacilli may result in infection and contribute to disease transmission16. Despite global efforts to control tuberculosis, it remains a major public health problem due to factors such as poverty, malnutrition, overcrowding, and poor living conditions17. In addition, conditions that impair the immune system, particularly human immunodeficiency virus (HIV) infection, significantly increase the risk of developing active tuberculosis. Individuals with weakened immune responses are less able to contain M. tuberculosis infection, resulting in an increased likelihood of progression from latent infection to active disease 16.

MATERIALS AND METHODS

Chemicals, Materials and Reagents

Distilled water, Methanol, Ethanol, Hydrochloric acid, Concentrated sulphuric acid, Analytical weighing balance, Soxhlet apparatus / Maceration apparatus, Beakers, Conical flasks, Measuring cylinders, Pipettes and droppers, Glass rods, Funnel and filter paper, Watch glass, Magnetic stirrer.

Collection and authentication of plant material

Fresh flowers of Pontederia crassipes were collected from a pond in Guntur during the month of March. The collected plant material was cleaned to remove adhering impurities and authenticated by a taxonomist from Acharya Nagarjuna University.

Preparation of ethanolic extract of pontederia crassipes flower

Fresh flowers of Pontederia crassipes were collected and washed thoroughly to remove dust and other adhering impurities. The petals were separated manually and weighed accurately. About 150 g of fresh flower petals were taken for extraction. The petals were immersed in 150 mL of ethanol in a clean glass container and kept in a dark place for three days to facilitate extraction of phytoconstituents. After completion of the extraction process, the extract was filtered using filter paper to remove insoluble materials and plant debris. The filtrate obtained was initially shade dried and then subjected to sun drying for further evaporation of the solvent. The partially concentrated extract was later heated gently using a heating mantle to obtain a concentrated solid mass. The dried mass obtained was triturated using a mortar and pestle to produce a fine powder. The prepared ethanolic extract powder was stored in an airtight container and used for preliminary phytochemical screening and in vitro anti-tubercular activity studies.

Figure 2. Freshly collected flowers of Pontederia crassipes used for phytochemical and biological investigations.

Preliminary phytochemical screening of Water Hyacinth

The ethanolic and aqueous extracts of Water Hyacinth were subjected to preliminary phytochemical screening using standard qualitative tests to detect the presence of various secondary metabolites18. The results of the screening, indicating the presence or absence of each phytoconstituent, are presented in Table below.

Table 1. Preliminary phytochemical screening of ethanolic and aqueous extracts of Pontederia crassipes flowers.

Sr. No

Phytoconstituents

Ethanolic extract

Aqueous extract

1.

Alkaloids

+

+

2.

Anthraquinones

-

-

4.

Flavonoids

+

+

5.

Tannins

-

+

6.

Steroids

+

-

7.

Terpenoids

+

-

8.

Saponins

-

-

10.

Phenolic Compounds

+

-

+ = present, − = absent

IN SILICO STUDIES

Selection and Preparation of Target Protein

Molecular docking studies were carried out to investigate the interaction between the phytoconstituents of Pontederia crassipes flower and the selected target protein of Mycobacterium tuberculosis. The three-dimensional crystal structure of the target protein, Enoyl-acyl Carrier Protein Reductase (InhA), was retrieved from the Protein Data Bank (PDB) with PDB ID 4P8N. The downloaded protein structure was carefully examined and prepared for docking studies. Water molecules, co-crystallized ligands, and other unwanted heteroatoms present in the structure were removed to avoid interference during docking. The prepared protein structure was then saved in the appropriate format and utilized as the receptor molecule for further molecular docking analysis. The active binding site of the protein was identified based on the reported ligand-binding residues and structural information available in the Protein Data Bank. The prepared receptor structure served as the target for evaluating the binding potential of the selected phytoconstituents.

Figure 3: Three-dimensional structure of InhA enzyme (PDB ID: 4P8N)

  • PDB ID: 4P8N
  • PDB DOI: https://doi.org/10.2210/pdb4P8N/pdb
  • Classification: Oxidoreductase/ Oxidoreductase Inhibitor
  • Organism(s): Mycobacterium tuberculosis H37Rv
  • Source: Protein Data Bank (PDB)
  • Experimental Method: X-ray diffraction
  • Expression System: Escherichia coli BL21(DE3)
  • Resolution: 1.79 Å

Ligand Preparation

The phytoconstituents reported from Pontederia crassipes flower were selected for molecular docking studies. The chemical structures of the selected compounds were retrieved from the PubChem database in SDF format. The downloaded structures were converted into the appropriate format and subjected to energy minimization prior to docking. The prepared ligands were then used for docking against the target protein. Selected ligands included rutin, β-sitosterol, orientin, isovitexin, luteolin, myricetin, quercetin, chlorogenic acid, kaempferol, tricin, gossypetin, azaleatin, apigenin, naringenin, chrysoeriol and other phytoconstituents identified from Pontederia crassipes flowers.

Molecular Docking Studies

Molecular docking was performed using pyrxautodock vina docking software to predict the binding orientation and affinity of the selected phytoconstituents within the active site of the target protein. Docking is a computational technique that predicts the most favorable interaction between a ligand and a receptor molecule. The prepared protein was used as the receptor, while the selected phytoconstituents were treated as ligands. During the docking process, multiple binding conformations were generated and evaluated using a scoring function. The binding affinity values were expressed in kcal/mol. A more negative docking score indicates stronger binding between the ligand and the receptor protein. The docking study was performed to identify potential anti-tubercular compounds from Pontederia crassipes flower extract and to understand their molecular interactions with the target protein.

Protein–Ligand Interaction Analysis

Following docking, the best binding pose of each ligand was selected based on the docking score and interaction profile. The docked complexes were analyzed to identify amino acid residues involved in binding.Various molecular interactions such as hydrogen bonding, hydrophobic interactions, van der Waals forces, π-π interactions, and electrostatic interactions were evaluated. The strength and nature of these interactions were considered important factors influencing ligand binding and stability within the active site of the target protein.

Visualization of Docked Complexes

The docked protein–ligand complexes were visualized using molecular visualization software. Both two-dimensional (2D) and three-dimensional (3D) interaction diagrams were generated to provide a detailed understanding of the binding mechanism. The interaction maps were used to identify the key amino acid residues involved in ligand binding and to compare the interaction patterns of different phytoconstituents with the target protein.

ADME Prediction Studies

The pharmacokinetic properties of the selected phytoconstituents were evaluated using the ADMETlab 2.0 web server. ADME analysis was carried out to assess the Absorption, Distribution, Metabolism, and Excretion characteristics of the compounds. Parameters including molecular weight, hydrogen bond donors, hydrogen bond acceptors, lipophilicity (LogP), gastrointestinal absorption, bioavailability score, and Lipinski's Rule of Five were determined. The obtained results were used to evaluate the drug-likeness and pharmacokinetic suitability of the selected phytoconstituents as potential anti-tubercular agents.

IN VITRO STUDIES

In Vitro Anti-Tubercular Activity by Microplate Alamar Blue Assay (MABA)

The anti-tubercular activity of Water Hyacinth (Eichhornia crassipes) flower extract was evaluated using the Microplate Alamar Blue Assay (MABA) against Mycobacterium tuberculosis. MABA is a rapid, sensitive, and cost-effective colorimetric method widely used for the screening of compounds with anti-tubercular activity. The assay is based on the reduction of the blue-colored Alamar Blue reagent (resazurin) to a pink-colored product (resorufin) by metabolically active bacterial cells. The color change serves as an indicator of bacterial growth, viability, and metabolic activity of the microorganism. In the presence of an effective anti-tubercular agent, bacterial growth is inhibited and the blue color is retained, whereas active bacterial growth results in a change from blue to pink.

Procedure

    1. Mycobacterium tuberculosis culture grown on Lowenstein–Jensen (LJ) medium was suspended in sterile Middlebrook 7H9 broth supplemented with 0.2% glycerol and 10% OADC (oleate-albumin dextrose-catalase) enrichment. The suspension was diluted and a 1:20 dilution used as the inoculum for the assay.
    2. All experimental procedures were carried out under appropriate biosafety conditions.
    3. Sterile deionized water (200 µL) was added to the outer perimeter wells of a sterile 96-well microplate to minimize evaporation during incubation.
    4. Each test well received 100 µL of Middlebrook 7H9 broth, followed by serial dilutions of the Water Hyacinth flower extract to obtain concentrations of 25, 12.5, 6.25, 3.125, 1.56, and 0.78 µg/ml.
    5. The bacterial inoculum was added to the wells containing the test sample. Rifampicin (3.125 µg/ml) was used as the reference standard.
    6. The microplates were covered and sealed with parafilm and incubated at 37°C for five days.
    7. After incubation, 25 µL of a freshly prepared 1:1 mixture of Alamar Blue reagent and 10% Tween 80 was added to each well, followed by further incubation for 24 hours.
    8. A blue color indicated inhibition of bacterial growth, whereas a pink color indicated bacterial growth.
    9. The Minimum Inhibitory Concentration (MIC) was determined as the lowest concentration that prevented the color change from blue to pink.

RESULT AND DISSCUSSION

Molecular Docking Score (pdb id: 4P8N)

Molecular docking studies were carried out to evaluate the binding affinity of selected phytoconstituents reported from Pontederia crassipes flowers against the selected Mycobacterium tuberculosis target protein. The docking analysis was performed to predict the interaction of each phytoconstituent with the active site of the protein and to identify compounds with potential anti-tubercular activity, A total of 35 phytoconstituents were screened and their binding scores were compared with the standard ligand BTZ043. The docking score and amino acid interactions obtained for each compound are presented in Table 6.1. Compounds with more negative binding scores were considered to possess stronger binding affinity toward the target protein. The results revealed variations in binding affinity among the selected phytoconstituents, indicating differences in their interaction with the target protein. The detailed docking scores and interacting amino acid residues are shown below. Among all the compounds studied, rutin showed the highest binding affinity with a docking score of -11.4 kcal/mol, followed by β-sitosterol (-10.2 kcal/mol), orientin (-9.8 kcal/mol), and isovitexin (-9.7 kcal/mol). The standard drug BTZ043 showed a docking score of -6.7 kcal/mol. Several phytoconstituents(i.e, 18 ligands) showed better binding scores than the standard drug, indicating good interaction with the target protein.

Table 2 - Molecular Docking Results of Selected Phytoconstituents of Pontederia crassipes

Sr. No

Ligand

Binding Score

Interactions

1

Rutin

-11.4

TYR, PRO, LYS, ARG, GLN, VAL, ASN, SER, TYR, TRP

2

Beta-sitosterol

-10.2

GLU, ALA, TYR, TRP, PHE, LEU

3

Orientin

-9.8

LYS, TYR, ARG, GLY, CYS, HIS, ASN, LYS, ALA

4

Isovitexin

-9.7

GLY, CYS, ARG, VAL, GLY, LYS, CYS, LYS, HIS, PRO, ILE, SER

5

Luteolin

-9.0

PRO, PHE, LYS, TYR, SER, ASN, HIS, CYS, VAL

6

Myrcetin

-8.9

GLY, VAL, LYS, GLN, CYS, ASN

7

Quercetin

-8.9

TYR, GLY, GLN, CYS, LYS, PRO

8

Chlorogenic acid

-8.8

GLY, TYR, ALA, VAL, PRO, ILE, SER, ARG, GLY, ALA

9

Kaempferol

-8.8

GLY, PRO, LYS, HIS, GLN, CYS

10

Tricin

-8.8

VAL, GLY, LYS, TYR, GLN, CYS, ASN, PRO, VAL, ILE

11

Gossypetin

-8.7

VAL, LYS, CYS, ASN, GLN, HIS, LYS

12

Azaleatin

-8.5

CYS, PRO, HIS, TYR, SER, ALA, ARG

13

Apigenin

-8.4

LYS, VAL, GLY, ARG, LYS, CYS, ASN, GLN

14

Naringenin

-8.3

SER, ILE, ALA, VAL, LYS, CYS, HIS, GLN

15

Chrysoeriol

-8.2

ARG, GLN, ASN, CYS, GLY, VAL, LYS, ILE, VAL, PRO

16

Ferulic acid

-6.8

TYR, ALA, CYS, ILE, VAL, LEU, THR, ARG, GLY

17

P-Coumaric acid

-6.7

GLY, LEU, THR, ARG, TYR, ILE, VAL, CYS, ALA

18

Syringic acid

-6.7

GLY, ILE, ALA, ALA, GLY, MET, GLY

19

(Standard) BTZ043

-6.7

LYS, VAL, CYS, ASN, GLN, HIS, TYR, PRO, ALA, ILE, VAL, CYS, ARG

20

Caffeic acid

-6.6

SER, ILE, LYS, ALA, VAL, ARG, GLY, LEU, THR

21

Oleic acid

-6.5

ARG, ALA, VAL, TRP, TYR, TRP, PHE, LEU

22

Linolenic acid

-6.4

VAL, LEU, PHE, TRP, ALA, TYR

23

Vanillic acid

-6.4

ILE, GLY, MET, ALA, ALA, ALA, GLY, THR, GLY, ARG, GLY

24

Gallic acid

-6.3

GLY, ILE, GLY, ALA, ALA, GLY THR

25

Protocatechuic acid

-6.2

GLY, ARG, GLY, THR, GLY, ALA, ALA, ILE, GLY

26

Stearic acid

-6.0

PHE, TRP, TYR, ALA, VAL, ARG, THR

27

Salicylic acid

-5.9

ILE, ALA, ALA, GLY, THR, GLY

28

Palmitic acid

-5.8

ARG, THR, ALA, VAL, TYR, TRP, LEU, LEU

29

2-Methyl Resorcinol

-5.6

ILE, GLY, ALA, GLY, ALA

30

4-Methyl Resorcinol

-5.4

ALA, ALA, GLY, ILE, GLY

31

Lauric acid

-5.4

TRP, TYR, PHE, LEU

32

Myristic acid

-5.3

PHE, PHE, LEU, LEU, PHE, TRP

33

Catechol

-5.2

ALA, ILE, GLY, MET, ALA, GLY

34

Pyrogallol

-5.2

ALA, ALA, ALA, SER

35

Resorcinol

-5.0

PHE, GLY, LEU, LYS, GLN

 

Protein–Ligand Interaction Analysis

The docked complexes were further analyzed to understand the interaction pattern of the selected phytoconstituents with the active site of the target protein. The 2D and 3D interaction diagrams were generated to visualize the binding mode and identify the amino acid residues involved in ligand binding.

Figure 4: 3D and 2D interactions of Rutin

Figure 5: 3D and 2D interactions of Beta-sitosterol

Figure 6: 3D and 2D interactions of Orientin

Figure7: 3D and 2D interactions of Isovitexin

Figure 8: 3D and 2D interactions of Luteolin

Figure 9: 3D and 2D interactions of Myrcetin

Figure 10: 3D and 2D interactions of Quercetin

Figure 11: 3D and 2D interactions of Chlorogenic acid

Figure 12: 3D and 2D interactions of Kaempferol

Figure 13: 3D and 2D interactions of Tricin

Figure 14: 3D and 2D interactions of Gossypetin

Figure 15: 3D and 2D interactions of Azaleatin

Figure 16: 3D and 2D interactions of Apigenin

Figure 17: 3D and 2D interactions of Naringenin

Figure 18: 3D and 2D interactions of Chrysoeriol

Figure 19: 3D and 2D interactions of Ferulic acid

Figure 20: 3D and 2D interactions of P-Coumaric acid

Figure 21: 3D and 2D interactions of Syringic acid

Figure 22: 3D and 2D interactions of (Standard) BTZ043

Figure 23: 3D and 2D interactions of Caffeic acid

Figure 24: 3D and 2D interactions of Oleic acid

Figure 25: 3D and 2D interactions of Linolenic acid

Figure 26:3D and 2D interactions of Vanillic acid

Figure 27: 3D and 2D interactions of Gallic acid

Figure 28: 3D and 2D interactions of Protocatechuic acid

Figure 29: 3D and 2D interactions of Stearic acid

Figure 30: 3D and 2D interactions of Salicylic acid

Figure 31: 3D and 2D interactions of Palmitic acid

Figure 32: 3D and 2D interactions of 2-Methyl Resorcinol

Figure 33: 3D and 2D interactions of 4-Methyl Resorcinol

Figure 34: 3D and 2D interactions of Lauric acid

Figure 35: 3D and 2D interactions of Myristic acid

Figure 36:3D and 2D interactions of Catechol

Figure 37: 3D and 2D interactions of Pyrogallol

Figure 38: 3D and 2D interactions of Resorcinol

ADMET Result

ADMET prediction studies were carried out to evaluate the drug-likeness and pharmacokinetic properties of the selected phytoconstituents of Pontederia crassipes. The compounds were analyzed for their absorption, distribution, metabolism, excretion and toxicity characteristics using an online prediction tool.

The ADME profiles of the selected compounds, along with their SMILES notation, chemical structures, and bioavailability radar plots, are presented below. These results provide useful information regarding the suitability of the compounds for further drug development studies.

Table 3: ADMET Properties of Selected Phytoconstituents of Pontederia crassipes

Sr. No

Compound name

SMILES

Structures

Radar images

1

Rutin

C[C@H]1[C@@H]

([C@H]([C@H]([C@@H]

(O1)OC[C@@H]2[C@H]

([C@@H]([C@H]([C@@H]

(O2)OC3=C(OC4=CC(=CC

(=C4C3=O)O)O)C5=CC(=C

(C=C5)O)O)O)O)O)O)O)O

2

Beta-sitosterol

CC[C@H](CC[C@@H](C)

[C@H]1CC[C@@H]2[C@@]

1(CC[C@H]3[C@H]2CC=C4

[C@@]3(CC[C@@H](C4)O)

C)C)C(C)C

3

Orientin

C1=CC(=C(C=C1C2=CC(=O)

C3=C(O2)C(=C(C=C3O)O)

[C@H]4[C@@H]([C@H]

([C@@H]([C@H](O4)CO)O)

O)O)O)O

4

Isovitexin

C1=CC(=CC=C1C2=CC(=O)

C3=C(O2)C=C(C(=C3O)

[C@H]4[C@@H]([C@H]

([C@@H]([C@H](O4)CO)O)O)O)O)O

5

Luteolin

C1=CC(=C(C=C1C2=CC

(=O)C3=C(C=C(C=C3O2)

O)O)O)O

7

Quercetin

C1=CC(=C(C=C1C2=C

(C(=O)C3=C(C=C(C=C3O2)

O)O)O)O)O

8

Chlorogenic acid

C1[C@H]([C@H]([C@@H]

(C[C@@]1(C(=O)O)O)OC

(=O)/C=C/C2=CC(=C(C=C2)

O)O)O)O

9

Kaempferol

C1=CC(=CC=C1C2=C

(C(=O)C3=C(C=C(C=C3O2)

O)O)O)O

10

Tricin

COC1=CC(=CC(=C1O)OC)

C2=CC(=O)C3=C(C=C

(C=C3O2)O)O

11

Gossypetin

C1=CC(=C(C=C1C2=C

(C(=O)C3=C(O2)C(=C

(C=C3O)O)O)O)O)O

12

Azaleatin

COC1=CC(=CC2=C1C(=O)

C(=C(O2)C3=CC(=C(C=C3)

O)O)O)O

13

Apigenin

C1=CC(=CC=C1C2=CC

(=O)C3=C(C=C(C=C3O2)

O)O)O

14

Naringenin

C1[C@H](OC2=CC(=CC

(=C2C1=O)O)O)C3=CC=C

(C=C3)O

15

Chrysoeriol

COC1=C(C=CC(=C1)C2=

CC(=O)C3=C(C=C(C=C3O2)

O)O)O

16

Ferulic acid

COC1=C(C=CC(=C1)/

C=C/C(=O)O)O

17

P-Coumaric acid

C1=CC(=CC=C1/C=

C/C(=O)O)O

18

Syringic acid

COC1=CC(=CC(=C1O)

OC)C(=O)O

19

(Standard) BTZ043

C[C@H]1COC2(O1)

CCN(CC2)C3=NC(=O)

C4=C(S3)C(=CC(=C4)C(F)

(F)F)[N+](=O)[O-]

Physiochemical Properties of selected Compounds

The physicochemical properties of the selected phytoconstituents were evaluated to understand their chemical characteristics and suitability for drug development. Parameters such as molecular weight, molecular volume, density, hydrogen bond acceptors, hydrogen bond donors, topological polar surface area, rotatable bonds, ring count, aqueous solubility, and lipophilicity were analyzed. The physicochemical properties of the selected compounds are lipophilic were analyzed. The physiochemical properties of the selected compounds are presented in the table 4

Table 4: Physicochemical Properties of Selected Phytoconstituents of Pontederia crassipes

Sr.

No

Compound name

MW

Vol

Dense

nHA

nHD

TPSA

nRot

nRing

Log S

log P

1

Rutin

610.15

552.3177

1.104708

16

10

269.43

6

5

-2.39666

0.986122

2

Beta-sitosterol

414.39

482.068

0.859609

1

1

20.23

6

4

-7.22133

8.004089

3

Orientin

448.1

413.1471

1.084601

11

8

201.28

3

4

-3.63145

0.671557

4

Isovitexin

432.11

404.3569

1.068635

10

7

181.05

3

4

-3.45041

0.934773

5

Luteolin

286.05

273.9766

1.044067

6

4

111.13

1

3

-4.01744

2.247147

6

Quercetin

302.04

282.7668

1.068159

7

5

131.36

1

3

-3.72159

1.447712

7

Chlorogenic acid

354.1

331.4726

1.068263

9

6

164.75

5

2

-2.95844

1.035675

8

Kaempferol

286.05

273.9766

1.044067

6

4

111.13

1

3

-3.64796

1.965317

9

Tricin

330.07

317.3587

1.040053

7

3

109.36

3

3

-4.0702

2.483805

10

Gossypetin

318.04

291.557

1.090833

8

6

151.59

1

3

-3.58887

1.264295

11

Azaleatin

316.06

300.0628

1.053313

7

4

120.36

2

3

-3.66977

1.492755

12

Apigenin

270.05

265.1863

1.018341

5

3

90.9

1

3

-4.21599

2.980918

13

Naringenin

272.07

267.8228

1.015858

5

3

86.99

1

3

-4.02073

2.595634

14

Chrysoeriol

300.06

291.2725

1.030169

6

3

100.13

2

3

-4.00313

2.67117

15

Ferulic acid

194.06

194.9385

0.995494

4

2

66.76

3

1

-2.36392

1.647679

16

 

P-Coumaric acid

164.05

168.8523

0.971559

3

2

57.53

2

1

-2.11364

1.440249

17

Syringic acid

198.05

189.0692

1.0475

5

2

75.99

3

1

-2.1659

1.209245

18

(Standard) BTZ043

431.08

366.1967

1.177181

8

0

94.8

3

4

-5.03601

3.483436

Drug-likeness properties of selected compounds

The drug-likeness properties of the selected phytoconstituents were evaluated using various prediction models. Parameters such as QED, Lipinski's Rule of Five, Ghose filter, Pfizer rule, GSK rule, Golden Triangle rule, and bioavailability score were analyzed to assess the suitability of the compounds for drug development. The results obtained for the selected compounds are presented in Table 5

Table 5: Drug-Likeness Properties of Selected Phytoconstituents of Pontederia crassipes

Sr. No

Compound name

QED

Lipinski

Violations

Pfizer

GSK

Golden triangle

Bioavailability Score

1

Rutin

0.14

1

0

1

1

0.17

2

Beta-sitosterol

0.436

0

1

1

1

0.55

3

Orientin

0.247

1

0

1

0

0.17

4

Isovitexin

0.3

0

0

1

0

0.55

5

Luteolin

0.511

0

0

0

0

0.55

7

Quercetin

0.434

0

0

0

0

0.55

8

Chlorogenic acid

0.234

0

0

0

0

0.11

9

Kaempferol

0.546

0

0

0

0

0.55

10

Tricin

0.677

0

0

0

0

0.55

11

Gossypetin

0.293

0

0

0

0

0.55

12

Azaleatin

0.535

0

0

0

0

0.55

13

Apigenin

0.632

0

0

0

0

0.55

14

Naringenin

0.742

0

0

0

0

0.55

15

Chrysoeriol

0.672

0

0

0

0

0.55

16

Ferulic acid

0.715

0

0

0

1

0.85

17

P-Coumaric acid

0.651

0

0

0

1

0.85

18

Syringic acid

0.76

0

0

0

1

0.56

19

(Standard) BTZ043

0.532

0

0

1

0

0.55

Absorption parameter of selected compounds

The absorption properties of the selected phytoconstituents were evaluated to predict their ability to be absorbed and transported in the body. Parameters such as Caco-2 permeability, MDCK permeability, P-glycoprotein (P-gp) inhibition, P-gp substrate status, human intestinal absorption (HIA), and oral bioavailability at different levels (F20%, F30%, and F50%) were analyzed. The results obtained for the selected compounds are presented in Table 6.

Table 6: Absorption Parameters of Selected Phytoconstituents of Pontederia crassipes

Compound name

Caco-2 Permeability

MDCK Permeability

Pgp inhibitor

Pgp substrate

HIA

F20%

F30%

F50%

Rutin

-6.54652

-5.02701

6.22E-08

0.699256

0.639735

0.772111

0.999751

0.999936

Beta-sitosterol

-5.12242

-4.93599

7.49E-05

0.218762

3.58E-07

0.002376

0.065338

0.986971

Orientin

-6.20807

-5.02164

3.11E-07

0.239122

0.716416

0.822009

0.999488

0.999405

Isovitexin

-6.25701

-5.09016

3.00E-06

0.474819

0.318659

0.623366

0.978318

0.991547

Luteolin

-5.1916

-4.79896

0.000941

0.209188

0.014605

0.925496

0.992087

0.998494

Quercetin

-6.17681

-4.92272

0.027569

0.030731

0.133589

0.5038

0.99108

0.998593

Chlorogenic acid

-6.42616

-5.15807

2.56E-06

0.07899

0.106257

0.99152

0.995865

0.99921

Kaempferol

-5.96934

-4.90902

0.14215

0.163041

0.015143

0.084482

0.715565

0.983332

Tricin

-5.16639

-4.83566

0.388394

0.305905

0.033933

0.102202

0.642935

0.990823

Gossypetin

-6.13648

-4.94955

0.002875

0.004764

0.20724

0.889248

0.997534

0.999536

Azaleatin

-5.39997

-4.84763

0.031732

0.015429

0.22784

0.622675

0.970391

0.995645

Apigenin

-5.1286

-4.75883

0.003726

0.312263

0.001684

0.565497

0.83683

0.985273

Naringenin

-4.9873

-4.76161

0.955773

0.186026

0.00045

0.002009

0.92546

0.998472

Chrysoeriol

-4.98933

-4.80238

0.029837

0.434247

0.006703

0.414727

0.857439

0.994129

Ferulic acid

-4.98863

-4.79135

0.00451

0.050445

0.249424

0.956667

0.932978

0.993275

P-Coumaric acid

-4.86029

-4.81154

0.00447

0.018582

0.082512

0.979971

0.960873

0.993122

Syringic acid

-5.19884

-4.78484

0.616712

0.333231

0.040125

0.087448

0.025154

0.362649

(Standard) BTZ043

-4.68246

-4.66042

0.579196

0.001558

0

0.002343

0.000356

0.000785

Distribution and metabolism parameter of selected molecules

The distribution and metabolism properties of the selected phytoconstituents were evaluated to predict their behavior in the body after absorption. Distribution parameters such as plasma protein binding (PPB), volume of distribution (VD), blood-brain barrier (BBB) permeability, and fraction unbound (Fu) were analyzed. Metabolic properties were assessed based on their interaction with major cytochrome P450 enzymes, including CYP1A2, CYP2C19, CYP2C9, CYP2D6, and CYP3A4, as inhibitors or substrates. The results are presented in Table 7

Table 7: Distribution and Metabolism Parameters of Selected Phytoconstituents of Pontederia crassipes

Compound name

Distribution

 

Metabolism

CYP1A2

CYP2C19

CYP2C9

CYP2D6

CYP3A4

PPB %

VD

BBB

Fu

Inhibitor

Substrate

Inhibitor

Substrate

Inhibitor

Substrate

Inhibitor

Substrate

Inhibitor

Substrate

Epigallocatechin-3-gallate (EGCG)

85.0054

-0.05883

3.59E-05

14.65911

0.0001

0.00364

1.44E-07

1.07E-06

1.85E-06

7.47E-05

2.26E-06

1.48E-07

0.029205

2.29E-09

Epigallocatechin (EGC)

86.93946

-0.24377

0.045148

12.44312

3.27E-07

5.92E-09

0.00045

0.038744

0.312381

1.78E-07

0.008317

0.020665

0.062234

0.993145

Epicatechin-3-gallate (ECG)

84.35659

-0.0114

0.015552

13.40785

0.486396

0.000106

3.64E-07

2.01E-07

0.000168

0.003209

7.35E-06

0.000114

0.11294

1.33E-07

Epicatechin (EC)

86.16372

-0.06469

0.002779

11.37636

0.406847

5.64E-06

9.64E-07

8.03E-09

5.66E-05

0.01849

0.000394

0.029807

0.848776

2.13E-07

Gallocatechin-3-gallate (GCG)

97.64169

-0.61376

0.011543

2.286002

0.999923

0.696097

0.010235

0.000137

0.001308

0.137756

0.577914

0.996236

0.997596

1.57E-05

Catechin

98.65997

-0.87913

0.000445

1.131221

0.998312

0.38429

0.005855

4.87E-05

0.432249

0.029644

0.00018

0.978297

0.936699

1.34E-06

Theaflavin

64.83117

-0.01156

0.000187

31.62116

4.12E-09

4.07E-12

3.34E-06

1.01E-09

2.90E-07

0.003441

1.13E-06

5.51E-10

3.97E-08

6.88E-08

Theaflavin-3-gallate

97.88079

-0.81165

0.000951

1.360189

0.996672

0.598314

0.132402

0.000515

0.799358

0.518549

0.00489

0.994622

0.974528

0.001706

Quercetin

97.72338

-0.53168

0.005249

1.564414

0.999999

0.985651

0.684985

0.194315

0.035482

0.959343

0.983648

0.999938

0.99402

9.30E-05

Kaempferol

98.52682

-0.83619

0.000264

1.495122

0.982766

0.013907

0.00055

6.76E-06

0.049458

0.006081

8.36E-05

0.220942

0.864141

9.38E-08

Rutin

96.53472

-0.46277

0.013498

3.858461

0.999925

0.469866

0.112379

7.04E-05

0.002128

0.673408

0.957457

0.999721

0.999871

0.000209

Isoquercitrin

83.49062

-0.07666

0.000153

7.284942

0.585673

0.678004

0.52612

0.000511

0.948157

0.158488

0.016063

0.856458

0.998653

2.24E-05

Ellagic acid

68.54447

-0.35259

0.004062

2.192784

0.999997

0.769397

0.776057

0.024724

0.019854

0.923298

0.980464

0.999923

0.998029

0.000369

Tofacitinib

31.12627

0.082806

0.001125

25.19214

0.018324

0.000272

0.000783

0.016178

0.018414

0.13468

0.001132

0.016114

0.00035

0.000224

Rutin

-

-

0.001293

25.19515

0.10884

0.000369

0.00059

0.000266

0.016005

0.02298

0.007144

0.45655

0.000614

0.000388

Beta-sitosterol

-

-

0.216208

18.66545

0.000455

0.020249

0.010511

0.040752

0.003657

0.106528

0.007765

0.001338

0.005643

0.001208

Orientin

-

-

0.033618

0.675012

0.034443

0.995599

0.998888

0.999505

0.999174

0.070813

0.000336

0.138596

0.697311

0.99916

Excretion and toxicity parameters of selected compounds

The excretion and toxicity properties of the selected phytoconstituents were evaluated to assess their safety and elimination characteristics. Excretion parameters such as plasma clearance (CL), half-life (T½), and other related properties were analyzed. Toxicity assessment included hepatotoxicity (HHT), drug-induced liver injury (DILI), mutagenicity, acute oral toxicity, maximum recommended daily dose (FDA MDD), skin sensitization, carcinogenicity, eye corrosion, eye irritation, and respiratory toxicity. The results obtained for the selected compounds are presented in Table 8

Table 8: Excretion and Toxicity Parameters of Selected Phytoconstituents of Pontederia crassipes

Compound name

Excretion

Toxicity

CL-plasma

T1/2

H-HT

DILI

Ames toxicity

Rat oral acute

FDAMDD

Skin Sensitization

Carcinogenicity

Eye corrosion

Eye irritation

Respiratory toxicity

Rutin

1.610724

4.616005

0.406325

0.936922

0.756376

0.044139

0.137174

0.997444

0.046632

3.59E-05

0.904546

0.030272

Beta-sitosterol

13.20525

0.5409

0.57298

0.222525

0.139152

0.110645

0.525163

0.989889

0.688429

0.495053

0.955914

0.87283

Orientin

3.932586

4.944092

0.505003

0.950639

0.837563

0.08168

0.223671

0.997222

0.257382

5.81E-05

0.853206

0.11455

Isovitexin

3.871632

4.011464

0.506147

0.855762

0.778409

0.097455

0.287624

0.978229

0.287779

9.48E-05

0.861198

0.068427

Luteolin

8.481936

1.373488

0.367101

0.796038

0.649526

0.509989

0.88046

0.928563

0.689341

0.464422

0.998498

0.729025

Quercetin

8.288988

1.58575

0.337382

0.782596

0.586042

0.479917

0.788757

0.896924

0.600177

0.603284

0.998417

0.673657

Chlorogenic acid

3.339708

2.757687

0.542861

0.29109

0.386054

0.053934

0.409879

0.986365

0.22493

0.008178

0.841379

0.108553

Kaempferol

5.694431

1.38759

0.386179

0.702867

0.545969

0.487835

0.804589

0.621322

0.715984

0.575216

0.998204

0.712718

Tricin

4.791202

1.465054

0.400191

0.740545

0.560591

0.481798

0.787196

0.58529

0.784716

0.520196

0.996416

0.824475

Gossypetin

12.45991

2.058904

0.344922

0.858424

0.635611

0.463759

0.606885

0.95449

0.422648

0.153493

0.994901

0.569838

Azaleatin

10.96262

1.573621

0.384501

0.776463

0.584112

0.434713

0.741871

0.866107

0.705817

0.652922

0.99682

0.59237

Apigenin

5.939475

1.202782

0.435063

0.742901

0.617563

0.520314

0.882218

0.64518

0.793352

0.37074

0.998086

0.777349

Naringenin

6.893972

1.311909

0.672792

0.219683

0.702948

0.500134

0.747017

0.746126

0.591036

0.039055

0.997435

0.266196

Chrysoeriol

4.922338

1.361561

0.403423

0.730784

0.651953

0.497305

0.838485

0.720911

0.75801

0.497947

0.997569

0.83647

Ferulic acid

8.358843

1.697795

0.701876

0.635605

0.25205

0.081005

0.194257

0.743

0.248972

0.761168

0.996626

0.607863

P-Coumaric acid

7.547604

1.570328

0.780272

0.562382

0.219234

0.062743

0.271227

0.783482

0.182531

0.827523

0.998567

0.48469

Syringic acid

3.223177

2.455797

0.484285

0.650168

0.32158

0.322106

0.119834

0.477641

0.415719

0.806909

0.99046

0.702334

(Standard) BTZ043

4.805134

0.668173

0.840828

0.986121

0.750391

0.912355

0.829641

0.807452

0.676369

7.95E-07

0.023264

0.650024

Environmental toxicity profile of designed molecules

The environmental toxicity profile of the selected phytoconstituents was evaluated to predict their possible impact on aquatic organisms and the environment. Parameters such as bioconcentration factor (BCF), Tetrahymena pyriformis toxicity (IGC50), Daphnia magna toxicity (LC50 DM), and fathead minnow toxicity (LC50 FM) were analyzed. The results obtained for the selected compounds are presented in Table 9

Table 9: Environmental Toxicity Profile of Selected Phytoconstituents of Pontederia crassipes

Compound name

BCF

IGC50

LC50DM

LC50FM

Rutin

0.533413

3.180953

4.680011

3.927314

Beta-sitosterol

3.132466

4.772487

5.144478

5.43717

Orientin

0.564484

3.162963

4.484141

3.805039

Isovitexin

0.373409

2.877814

4.19106

3.488637

Luteolin

1.287748

3.837745

4.522118

4.200997

Quercetin

1.210035

3.758566

4.485008

4.112

Chlorogenic acid

0.419095

3.045559

4.53114

3.936631

Kaempferol

1.241837

3.653071

4.37644

4.00664

Tricin

0.972922

3.575795

4.316165

3.774826

Gossypetin

1.029001

3.795287

4.589046

4.121624

Azaleatin

1.122729

3.629809

4.459033

4.074377

Apigenin

1.307611

3.69225

4.353479

3.986591

Naringenin

1.249839

3.712144

4.449478

4.020543

Chrysoeriol

1.06901

3.54394

4.281835

3.733888

Ferulic acid

0.183638

2.756398

3.979393

3.238442

P-Coumaric acid

0.386644

2.733626

3.79595

3.252875

Syringic acid

0.255189

2.686035

3.675891

3.09164

(Standard) BTZ043

2.069121

4.047093

5.762298

5.267161

Anti- TB Activity Using Microplate Alamar Blue Dye (MABA)

The ethanolic flower extract of Eichhornia crassipes (Water Hyacinth) was evaluated for anti-tubercular activity using the Microplate Alamar Blue Assay (MABA) against Mycobacterium tuberculosis.The extract and standard drug Rifampicin were tested at concentrations ranging from 0.78 to 25 µg/mL. At 25 µg/mL, complete inhibition was observed (blue color), while at 12.5 µg/mL partial inhibition was noted (purple color). At concentrations of 6.25, 3.125, 1.56, and 0.78 µg/mL, pink coloration indicated active bacterial growth with no significant inhibition. Thus, the MIC of the extract was found to be 25µg/mL. When compared to the standard drug Rifampicin, which showed inhibition at 3.125 µg/mL, the ethanolic extract of E. crassipes showed activity at a higher concentration. However, since it is a natural plant-based product, it is expected to have fewer side effects and a lower chance of causing drug resistance compared to synthetic anti-TB drugs. As drug resistance in tuberculosis is becoming a growing problem worldwide, natural plant extracts like E. crassipes could be a good alternative for future anti-TB treatment. Therefore, this extract shows good potential as a natural anti-tubercular agent.

Standard values for the Anti-TB test which was performed.

RIFAMPICIN: 3.125μg/ml.

Figure 39: Anti-tubercular activity of Rifampicin (Standard) at concentrations ranging from 0.78 to 25 µg/mL against Mycobacterium tuberculosis by MABA method

Anti TB activity results of the compounds:

Table 10: Sensitivity and Resistant pattern o Water Hyacinth extract and Rifampicin at  different concentrations against Mycobacterium tuberculosis

Sr. No

Sample and Standard

25

12.5

6.25

3.125

1.56

0.78

1.

WATER HYACINTH

S

S

R

R

R

R

2.

RIFAMPACIN (Standard)

S

S

S

S

R

R

NOTE: S- Sensitive, R- Resistant

Figure 40: Comparative anti-tubercular activity of ethanolic flower extract of Eichhornia crassipes (Water Hyacinth) and Rifampicin (Standard) at concentrations ranging from 0.78 to 25 µg/mL against Mycobacterium tuberculosis by MABA method.

Figure 41: Comparative Minimum Inhibitory Concentration (MIC) of Eichhornia crassipes (Water Hyacinth) extract and Rifampicin (Standard) against Mycobacterium tuberculosis by MABA method

CONCLUSION

From the work it was concluding that we evaluated Anti-tubercular activity of ethanolic extract of Pontederia crassipes (Water Hyacinth) flowers and identified the presence of phytochemicals like Glycosides, Flavanoids, tannins, saponins etc.In silico molecular docking studies demonstrated that several phytoconstituents of Pontederia crassipes exhibited strong binding affinity towards the selected target protein. Among the screened compounds, rutin, β-sitosterol, orientin, isovitexin, and luteolin showed the highest docking scores, indicating promising interactions with the target. ADMET analysis further suggested favorable drug-likeness and pharmacokinetic properties for the selected compounds, supporting their potential as lead molecules for future drug development. The in vitro studies demonstrated significant biological activity of the ethanolic extract of Pontederia crassipes, supporting the findings obtained from the molecular docking analysis. It has shown Anti-tubercular activity against Mycobacterium tuberculosis when compared with standard Rifampicin. The combined in vitro and in silico results suggest that the plant possesses promising therapeutic potential and may serve as a valuable source of bioactive compounds. However, further in vivo studies and clinical investigations are required to validate its efficacy and safety.

REFERENCES

  1. Hiba Hatim Hamad, Kais Kassim Ghaima, Ali Muayyednajem, Photochemical, antioxidant and antibacterial activities of some extracts of water hyacinth (Pontederia crassipes) leaves, International Journal of Current Microbiology and Applied Sciences; Vol. 4, Issue 6 ,2013; 1847 – 1851.
  2. Alka Rai et al. Water Hyacinth (Pontederia crassipes): Not Only an Invasive Weed with Hazard for Aquatic Ecosystem but Also a Useful Resourse of Sustainable Products, Journal of Applied Biology & Biotechnology; Volume 12 Issue 3, 2025; 2125-2136.
  3. Bhattacharya A, Kumar P, (2010) Water hyacinth as a potential biofuel crop. Electronic Journal of Environmental, Agricultural and Food Chemistry, 9(1), 112-122.
  4. Gebrehiwot, H., Dekebo, A., & Annisa, M. E. (2022). Chemical composition, pharmaco logical activities and biofuel production of Eichhornia crassipes (water hyacinth): a review. J. of the Turkish Chemical Society Section A: Chemistry, 9(3), 849-866. https://doi.org/10.18596/jotcsa.1033493.
  5. Malik, A. (2007). Environmental challenge vis-a vis opportunity. https://doi.org/10.1016/j.envint.2006.08.004
  6. Widad Ben Bakrim , Amine Ezzariai Eichhornia crassipes (Mart.) Solms: A Comprehensive Review of Its Chemical Composition, Traditional Use, and Value-Added Products, frontiers, 2022 Mar 18;13:842511. doi: 10.3389/fphar.2022.842511
  7. Gemechu Tolera, Assessment of water hyacinth (Pontederia crassipes) distribution and changes in Lake Koka and Lake Ziway through remote sensing techniques: Scientific Reports, 15, Article number: 16885 (2025)
  8. Seung Heon Lee, Tuberculosis Infection and Latent Tuberculosis, January 2016, Tuberculosis and Respiratory Diseases 79(4):201, DOI:10.4046/trd.2016.79.4.201
  9. Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2015;78(2):47–55. doi:10.4046/trd.2015.78.2.47.
  10.  Cronan MR. In the Thick of It: Formation of the Tuberculous Granuloma and Its Effects on Host and Therapeutic Responses. Front Immunol. 2022;13:820134. doi:10.3389/fimmu.2022.820134.
  11.  Cadena AM, Fortune SM, Flynn JL. Heterogeneity in tuberculosis. Nat Rev Immunol. 2017;17(11):691-702. doi:10.1038/nri.2017.69.
  12. Barry CE III, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol. 2009;7(12):845-855. doi:10.1038/nrmicro2236.
  13. Turner RD, Bothamley GH. Cough and the transmission of tuberculosis. The Journal of Infectious Diseases. 2015;211(9):1367-1372. DOI: 10.1093/infdis/jiu625.
  14. Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk factors for tuberculosis. Pulmonary Medicine. 2013;2013:828939. DOI: 10.1155/2013/828939.
  15. Lee JY, Kwon N, Goo GY, Cho SI. Inadequate housing and pulmonary tuberculosis: a systematic review. BMC Public Health. 2022;22:622. DOI: 10.1186/s12889-022-12879-6.
  16. Ayoola G, Coker H, Adesegun S, Adepoju-Bello A, Obaweya K, Ezennia EC, et al. Phytochemical screening and antioxidant activities of some selected medicinal plants used for malaria therapy in Southwestern Nigeria. Tropical journal of pharmaceutical research. 2008; 7(3):1019-24. Available from: https://doi.org/10.4314/tjpr.
  17. Agung Krismariono, Ernie Maduratna Setiawatie, Rita Yuana Rachmawati, Yosua Adi Setiawan, Hafidzah Nareswari Padmarini, Nurul Annisa Apriliyanti, Antibacterial Activity of Water Hyacinth (Pontederia Crassipes) Leaf Extract Against Bacterial Plaque from Gingivitis Patients, Jurnal Kesehatan Gigi;15(3), 2022: 966-971.
  18. Dr A Vaidya Soocheta, Evaluation of Antibacterial and Antifungal Susceptibility of Water Hyacinth, International Journal of Creative Research Thoughts (IJCRT); Volume 7, Issue 2, 2022; 563-567.
  19. Yasinta Izzah Afidati, Irma Josefina Savitri, Agung Krismariono, Inhibition Activity of Water Hyacinth Leaf Extract (Pontederia crassipes) against Aggregatibacteractinomycetemcomitans, Journal of Drug Delivery and Therapeutics; Vol 12, Issue 6, 2022; 2455-3891.
  20. Saraf K. R and Barate D. L, Antimicrobial Activity of Pontederia Crassipes Against Clinical Pathogens, International Journal of Pharmaceutical Research; Vol. 9, Issue, 6(A), 2018; 27260-27264.
  21. P. Jayanthi and P. Lalitha, Antimicrobial activity of solvent extracts of Pontederia crassipes (Mart.) Solms, International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS); 5(3), 2013:135-140.
  22. Hafidzah Nareswari Padmarini, Raniah Salma Voletta, Shifa Fauzia, Noer Ulfah, Komang Evan Wijaksana and Agung Krismariono, Inhibition activity of water hyacinth (Pontederia crassipes) leaf extract against Prevotella intermedia, Journal of International Dental and Medical Research (JIDMR); 16(01), 2022; 735–741.
  23. Asep Bayu Dani Nandiyanto, Muhammad Aziz,et., Progress in the utilization of water hyacinth as effective biomass material, Heliyon; 26: 2023; 24521–24568.
  24. Afsana Akter, Md. Kawsar Alam Nadim, Mariom Mitu, Md. Selim Reza, S.M. Abdul Alim and Md. Mohimenul Islam, Water Hyacinth: Potential Applications for Environmental Sustainability and Socio-economic Development, Current Research in Green and Sustainable Chemistry; Volume 16, Issue 1, 2023; 31-39.
  25. Dr. Mohammad Mashkur Ahmad, Dr. Md. Tanwir Alam, Dr. Shifat Naaz, Water Hyacinth is a Potential Aquatic Plant Used in Water Treatment: A Short Review, International Journal of Creative Research Thoughts (IJCRT); 13(7), 2023: 898-907.
  26. Bikash Baral and Geeta Shrestha Vaidya, Biological and Chemical Assessment of Water Hyacinth (Pontederia Crassipes (Mart.) Solms.) of Phewa Lake, Nepal, Scientific World; Vol. 9, No. 9, 2011.
  27. Ahmed M. Aboul-Enein, Sanaa M.M. Shanab, Emad A. Shalaby, Malak M. Zahran, David A. Lightfoot, and Hany A. El-Shemy, Cytotoxic and antioxidant properties of active principals isolated from water hyacinth against four cancer cells lines, Cancer Cell International; 14:397, 2014; 1-11.
  28. Adedeji Adebukola Adelodun, Usman Olamide Hassan, and Victor Oluwatobi Nwachukwu, Environmental, mechanical, and biochemical benefits of water hyacinth (Pontederia crassipes, Heliyon; 2020, 1-12.
  29. Anjanabha Bhattacharya and Pawan Kumar, Water hyacinth as a potential biofuel crop, Electronic Journal of Environmental, Agricultural and Food Chemistry (EJEAFChe);ISSN: 1579-4377, 2010; 112-122.
  30. Chin-Chyuan Chang, Hui-Ching Tan, and Winton Cheng, Effects of dietary administration of water hyacinth (Pontederia crassipes) extracts on the immune responses and disease resistance of giant freshwater prawn, Macrobrachium rosenbergii, Fish & Shellfish Immunology; vol 35, 2013; 92-100.
  31. NagassaDechassa and Belay Abate, Current Status of Water Hyacinth (Pontederia crassipes) in Ethiopia: Achievements, Challenges and Prospects: A Review, Journal of Agriculture and Food Research; Vol.10, No.12, 2020; 36-48.
  32. Olasunkanmi K. Awote, Adesegun G. Adeyemo, Jimoh O. Igbalaye, Rasaq B. Awosemo, Ajibola B. Ibrahim, Boluwatife E. Omolaja, Fidausi Abdulrafiu, Taiwo Fajobi, In Vitro Alpha-Amylase Inhibitory Activity, Antioxidant Activity and HPLC Analysis of Pontederia crassipes Methanol Extracts, International Journal of Pharmaceutical Sciences and Research (IJPSR); 5(12) 2021:2174-2181.
  33. Pandey D.K., Kauraw L.P., and Bhan V.M. Inhibitory effect of parthenium (parthenium hysterophorus) residue on growth of water hyacinth (Pontederia crassipes mart solms ) effect of leaf residue, Journal of Chemical Ecology; Vol. 19, No. 11, 1993; 2651-2662.
  34. Sher Wali, Khushnood ur Rehman, Barkat Ullah, Tabassum Yaseen and Gulzad Ahmad, Efficiency of common water hyacinth (Pontederia crassipes) in controlling growth of fungal and bacterial clinical strains, Pure and Applied Biology (PAB); 8(4), 2019: 2178-2186.
  35. P. Jayanthi and P. Lalitha, Antimicrobial activity of solvents extract of Pontederia crassipes (Maer.) solms, Asian Journal of Plant Science and Research; 45 (1): 2011; 13 – 22.
  36. C.J. Rodgers and M.D.  Furones, Anti-microbial agents in aqua culture, 2009; 1-12.
  37. Lata n and V. Dubey, Preliminary phytochemical screening of Pontederia crassipes, Journal of Pharmacy Research, 2010; 11-12.
  38. Wijittra Poonsawat, George Tsaiidis, Christos Tsekos, and Wiebren de Jong, Experimental studies of furfural production from water hyacinth (Pontederia Crassipes, Energy Science & Engineering (Wiley); 2016; 1-10.
  39. Diniatik, Eka Retnowati, Asmiyenti D. Djalil , Molecular Docking Analysis of Volatile Compounds from Fraction of Pontederia crassipes Herbs Ethanol Extract As α-Glucosidase Inhibitor, Indonesian Journal of Pharmaceutical Sciences and Technology (IJPST); 10 (1), 2020; 19-30.
  40. Alexander Patera Nugraha, Amelia Aisyiah Anwar, Aisyah Novianti, NastitiFaradilla Ramadhani, Ratri Maya Sitalaksmi, Muhammad Luthfi, Viol Dhea Kharisma, Rahmad Rifqi Fahreza, Triana Marchelina, Albertus Putera Nugraha, Tengku Natasha Eleena binti Tengku Ahmad Noor, Stigmasterol, Quercetin, and Anthocyanin in Pontederia crassipes as Host Modulation Therapy Candidate: A Bioinformatic Approach, Journal of International Dental and Medical Research; Volume16, 2023; 1067-1073.
  41. Gloria María Molina-Salinas, Jorge Bórquez, Alejandro Ardiles, Salvador Said-Fernández, Luis Alberto Loyola, Aurelio San-Martín, Isidro González-Collado, Antituberculosis activity of natural and semisynthetic azorellane and mulinane diterpenoids, Fitoterapia; Volume 81, Issue 1, 2010; Pages 50-54.
  42. Ryan J. Case, Yuehong Wang, Scott G. Franzblau, D. Doel Soejarto, Lohi Matainaho, Pius Piskaut, Advanced applications of counter-current chromatography in the isolation of anti-tuberculosis constituents from Dracaena angustifolia, Journal of Chromatography; Volume 1151, Issues 1–2, 2007; Pages 169-174.
  43. Juan D. Guzman, Antima Gupta, Dimitrios Evangelopoulos, Chandrakala Basavannacharya, Ludy C. Pabon, Erika A. Plazas, Diego R. Muñoz, Wilman A. Delgado, Luis E. Cuca, Wellman Ribon, Simon Gibbons, Sanjib Bhakta, Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium, Journal of Antimicrobial Chemotherapy; Volume 65, Issue 10, 2010;  Pages 2101–2107.
  44. Khalid A El Sayed, Piotr Bartyzel, Xiaoyu Shen, Tony L Perry, Jordan K Zjawiony, Mark T Hamann, Marine Natural Products as Antituberculosis Agents, Tetrahedron; Volume 56, Issue 7, 2000; 949-953.
  45. Diganta DeyDiganta Dey, Ratnamala Ray, Banasri Hazra, Antitubercular and Antibacterial Activity of Quinonoid Natural Products Against Multi-Drug Resistant Clinical Isolates, Phytotherapy Research;Volume28, Issue7, 2010; 1014-1021.
  46. GuidoF. Pauli, RyanJ, Case, Taichi Inui, Yuehong Wang, Sanghyun Cho, Nikolaus H. Fischer, Scott G. Franzblau, New perspectives on natural products in TB drug research, Life Sciences; Volume 78, Issue 5, 2005; 485-494.
  47. Gautam Kumar, Amrutha C, Natural products and their analogues acting against Mycobacterium tuberculosis: A recent update, Drug Development Research; Volume84, Issue5, 2023; 779-804.
  48. Yuan-Qiang Hu, Zhi Xu, Shu Zhang, Xiang Wu, Jun-Wei Ding, Lian-Shun FengRecent developments of coumarin-containing derivatives and their anti-tubercular activity, European Journal of Medicinal Chemistry; Volume 136, 2017; 122-130.
  49. Navneet Kishore, Bhuwan B. Mishra, Vyasji Tripathi, Vinod K. Tiwari, Alkaloids as potential anti-tubercular agents, Fitoterapia;Volume 80, Issue 3, 2009; 149-163.
  50. Diana Quan, Gayathri Nagalingam, Richard Payne, James A. Triccas, New tuberculosis drug leads from naturally occurring compounds, International Journal of Infectious Diseases;Volume 56, 2007; 212-220.
  51. Ali A. Rabaan, Mohammed Garout, Mohammed Aljeldah, Basim R. Al Shammari, Abdulsalam Alawfi, Amer Alshengeti, Mustafa A. Najim, Mohammed Alrouji, Yasir Almuhanna, Mohammed Alissa, Mutaib M. Mashraqi, Ameen S. S. Alwashmi, Mashael Alhajri, Souad Mohammed Alateah, Ramadan Abdelmoez Farahat &Ranjan K. Mohapatra, Anti-tubercular activity evaluation of natural compounds by targeting Mycobacterium tuberculosis resuscitation promoting factor B inhibition: An in silico study;Volume 28, 2024; 1057–1072.
  52.  Atul Kumar, Suman Srivastava, Garima Gupta, Vinita Chaturvedi, Natural Product Inspired Diversity Oriented Synthesis of Tetrahydroquinoline Scaffolds as Antitubercular Agent, ACS Combinatorial Science; Vol 13/Issue 1, 2020.
  53. Alka Pawar, Prakash Jha, Madhu Chopra, Uma Chaudhry, Daman Saluja, Screening of natural compounds that targets glutamate racemaseof Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids, Scientific Reports; 10, Article number: 949, 2020.
  54. Jidong Zhang, Christine Lair, Christine Roubert, Kwame Amaning, Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents, Cell; Volume 186, Issue 5, 2023; 1013-1025.
  55. Marlene Espinoza-Moraga, Nicholas M, Njuguna, Grace Mugumbate, Julio Caballero, Kelly Chibale, In silico Comparison of Antimycobacterial Natural Products with Known Antituberculosis Drugs, Journal of Chemical Information and Modeling; Vol 53/Issue 3, 2013.
  56. A.Sivakumar and G. Jayaraman, Anti-tuberculosis activity of commonly used medicinal plants of south India, Journal of Medicinal Plants Research; Vol. 5(31), 2011; 6881-6884.
  57. Haggag WM, Abou El Ella SM, Abouziena HF. Phytochemical analysis, antifungal, antimicrobial activities and application of Eichhornia crassipes against some plant pathogens. Planta Daninha. 2017;35:e017163071.
  58. Verma VK, Prakash O, Kumar RSR, Rani KV, Sehgal N. Water hyacinth (Eichhornia crassipes) leaves enhance disease resistance in Channa punctata from Vibrio harveyi infection. Journal of Basic and Applied Zoology. 2021;82(1):1-24.
  59. Chaiwarit T, Chanabodeechalermrung B, Kantrong N, Chittasupho C, Jantrawut P. Fabrication and evaluation of water hyacinth cellulose-composited hydrogel containing quercetin for topical antibacterial applications. Gels. 2022;8(12):767.
  60.  Islami LN, Oktiani BW, Wasiaturrahmah Y. Antibacterial effectiveness of water hyacinth (Eichhornia crassipes) leaf extract on the growth of Porphyromonas gingivalis. Dentin: JurnalKedokteran Gigi. 2023;7(2):63-68.
  61. Ratnani RD, Arianti FD, Sasongko NA. Exploring the potential of water hyacinth weed (Pontederia crassipes) as an environmentally friendly antifungal to realize sustainable development in lakes: A review. Case Studies in Chemical and Environmental Engineering. 2024;9:100702.
  62. Semu TC, Williams J, Cheng J, Mutingwende I, Chifamba J. Pontederia crassipes-biosynthesized silver nanoparticles: Characterization and antimicrobial activity against multidrug-resistant microorganisms. Journal of Advances in Medical and Pharmaceutical Sciences. 2024;26(6):1-16.
  63. El-Gendy AA, El-Banna MM. Eichhornia crassipes (Mart.) Solms: A comprehensive review of its chemical composition, traditional use and value-added products. Frontiers in Pharmacology. 2022;13:842511.
  64. Qin H, Zhang Y, Liu Y, et al. Allelopathic effects of water hyacinth (Eichhornia crassipes) on aquatic plants. PLoS ONE. 2010;5(10):e13200.
  65. Eden WT, Wahyuono S, Cahyono E, Astuti P. Phytochemical screening, antioxidant and cytotoxic activity of water hyacinth (Eichhornia crassipes) ethanolic extract. Tropical Journal of Natural Product Research. 2023;7(8):3606-3612.
  66. Powthong P, Suntornthiticharoen P. Comparative evaluation of antioxidant, antimicrobial and tyrosinase inhibitory activities of Centella asiatica and Eichhornia crassipes. Journal of Medical and Pharmaceutical Allied Sciences. 2023;12:5931-5938.

Reference

  1. Hiba Hatim Hamad, Kais Kassim Ghaima, Ali Muayyednajem, Photochemical, antioxidant and antibacterial activities of some extracts of water hyacinth (Pontederia crassipes) leaves, International Journal of Current Microbiology and Applied Sciences; Vol. 4, Issue 6 ,2013; 1847 – 1851.
  2. Alka Rai et al. Water Hyacinth (Pontederia crassipes): Not Only an Invasive Weed with Hazard for Aquatic Ecosystem but Also a Useful Resourse of Sustainable Products, Journal of Applied Biology & Biotechnology; Volume 12 Issue 3, 2025; 2125-2136.
  3. Bhattacharya A, Kumar P, (2010) Water hyacinth as a potential biofuel crop. Electronic Journal of Environmental, Agricultural and Food Chemistry, 9(1), 112-122.
  4. Gebrehiwot, H., Dekebo, A., & Annisa, M. E. (2022). Chemical composition, pharmaco logical activities and biofuel production of Eichhornia crassipes (water hyacinth): a review. J. of the Turkish Chemical Society Section A: Chemistry, 9(3), 849-866. https://doi.org/10.18596/jotcsa.1033493.
  5. Malik, A. (2007). Environmental challenge vis-a vis opportunity. https://doi.org/10.1016/j.envint.2006.08.004
  6. Widad Ben Bakrim , Amine Ezzariai Eichhornia crassipes (Mart.) Solms: A Comprehensive Review of Its Chemical Composition, Traditional Use, and Value-Added Products, frontiers, 2022 Mar 18;13:842511. doi: 10.3389/fphar.2022.842511
  7. Gemechu Tolera, Assessment of water hyacinth (Pontederia crassipes) distribution and changes in Lake Koka and Lake Ziway through remote sensing techniques: Scientific Reports, 15, Article number: 16885 (2025)
  8. Seung Heon Lee, Tuberculosis Infection and Latent Tuberculosis, January 2016, Tuberculosis and Respiratory Diseases 79(4):201, DOI:10.4046/trd.2016.79.4.201
  9. Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul). 2015;78(2):47–55. doi:10.4046/trd.2015.78.2.47.
  10.  Cronan MR. In the Thick of It: Formation of the Tuberculous Granuloma and Its Effects on Host and Therapeutic Responses. Front Immunol. 2022;13:820134. doi:10.3389/fimmu.2022.820134.
  11.  Cadena AM, Fortune SM, Flynn JL. Heterogeneity in tuberculosis. Nat Rev Immunol. 2017;17(11):691-702. doi:10.1038/nri.2017.69.
  12. Barry CE III, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol. 2009;7(12):845-855. doi:10.1038/nrmicro2236.
  13. Turner RD, Bothamley GH. Cough and the transmission of tuberculosis. The Journal of Infectious Diseases. 2015;211(9):1367-1372. DOI: 10.1093/infdis/jiu625.
  14. Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk factors for tuberculosis. Pulmonary Medicine. 2013;2013:828939. DOI: 10.1155/2013/828939.
  15. Lee JY, Kwon N, Goo GY, Cho SI. Inadequate housing and pulmonary tuberculosis: a systematic review. BMC Public Health. 2022;22:622. DOI: 10.1186/s12889-022-12879-6.
  16. Ayoola G, Coker H, Adesegun S, Adepoju-Bello A, Obaweya K, Ezennia EC, et al. Phytochemical screening and antioxidant activities of some selected medicinal plants used for malaria therapy in Southwestern Nigeria. Tropical journal of pharmaceutical research. 2008; 7(3):1019-24. Available from: https://doi.org/10.4314/tjpr.
  17. Agung Krismariono, Ernie Maduratna Setiawatie, Rita Yuana Rachmawati, Yosua Adi Setiawan, Hafidzah Nareswari Padmarini, Nurul Annisa Apriliyanti, Antibacterial Activity of Water Hyacinth (Pontederia Crassipes) Leaf Extract Against Bacterial Plaque from Gingivitis Patients, Jurnal Kesehatan Gigi;15(3), 2022: 966-971.
  18. Dr A Vaidya Soocheta, Evaluation of Antibacterial and Antifungal Susceptibility of Water Hyacinth, International Journal of Creative Research Thoughts (IJCRT); Volume 7, Issue 2, 2022; 563-567.
  19. Yasinta Izzah Afidati, Irma Josefina Savitri, Agung Krismariono, Inhibition Activity of Water Hyacinth Leaf Extract (Pontederia crassipes) against Aggregatibacteractinomycetemcomitans, Journal of Drug Delivery and Therapeutics; Vol 12, Issue 6, 2022; 2455-3891.
  20. Saraf K. R and Barate D. L, Antimicrobial Activity of Pontederia Crassipes Against Clinical Pathogens, International Journal of Pharmaceutical Research; Vol. 9, Issue, 6(A), 2018; 27260-27264.
  21. P. Jayanthi and P. Lalitha, Antimicrobial activity of solvent extracts of Pontederia crassipes (Mart.) Solms, International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS); 5(3), 2013:135-140.
  22. Hafidzah Nareswari Padmarini, Raniah Salma Voletta, Shifa Fauzia, Noer Ulfah, Komang Evan Wijaksana and Agung Krismariono, Inhibition activity of water hyacinth (Pontederia crassipes) leaf extract against Prevotella intermedia, Journal of International Dental and Medical Research (JIDMR); 16(01), 2022; 735–741.
  23. Asep Bayu Dani Nandiyanto, Muhammad Aziz,et., Progress in the utilization of water hyacinth as effective biomass material, Heliyon; 26: 2023; 24521–24568.
  24. Afsana Akter, Md. Kawsar Alam Nadim, Mariom Mitu, Md. Selim Reza, S.M. Abdul Alim and Md. Mohimenul Islam, Water Hyacinth: Potential Applications for Environmental Sustainability and Socio-economic Development, Current Research in Green and Sustainable Chemistry; Volume 16, Issue 1, 2023; 31-39.
  25. Dr. Mohammad Mashkur Ahmad, Dr. Md. Tanwir Alam, Dr. Shifat Naaz, Water Hyacinth is a Potential Aquatic Plant Used in Water Treatment: A Short Review, International Journal of Creative Research Thoughts (IJCRT); 13(7), 2023: 898-907.
  26. Bikash Baral and Geeta Shrestha Vaidya, Biological and Chemical Assessment of Water Hyacinth (Pontederia Crassipes (Mart.) Solms.) of Phewa Lake, Nepal, Scientific World; Vol. 9, No. 9, 2011.
  27. Ahmed M. Aboul-Enein, Sanaa M.M. Shanab, Emad A. Shalaby, Malak M. Zahran, David A. Lightfoot, and Hany A. El-Shemy, Cytotoxic and antioxidant properties of active principals isolated from water hyacinth against four cancer cells lines, Cancer Cell International; 14:397, 2014; 1-11.
  28. Adedeji Adebukola Adelodun, Usman Olamide Hassan, and Victor Oluwatobi Nwachukwu, Environmental, mechanical, and biochemical benefits of water hyacinth (Pontederia crassipes, Heliyon; 2020, 1-12.
  29. Anjanabha Bhattacharya and Pawan Kumar, Water hyacinth as a potential biofuel crop, Electronic Journal of Environmental, Agricultural and Food Chemistry (EJEAFChe);ISSN: 1579-4377, 2010; 112-122.
  30. Chin-Chyuan Chang, Hui-Ching Tan, and Winton Cheng, Effects of dietary administration of water hyacinth (Pontederia crassipes) extracts on the immune responses and disease resistance of giant freshwater prawn, Macrobrachium rosenbergii, Fish & Shellfish Immunology; vol 35, 2013; 92-100.
  31. NagassaDechassa and Belay Abate, Current Status of Water Hyacinth (Pontederia crassipes) in Ethiopia: Achievements, Challenges and Prospects: A Review, Journal of Agriculture and Food Research; Vol.10, No.12, 2020; 36-48.
  32. Olasunkanmi K. Awote, Adesegun G. Adeyemo, Jimoh O. Igbalaye, Rasaq B. Awosemo, Ajibola B. Ibrahim, Boluwatife E. Omolaja, Fidausi Abdulrafiu, Taiwo Fajobi, In Vitro Alpha-Amylase Inhibitory Activity, Antioxidant Activity and HPLC Analysis of Pontederia crassipes Methanol Extracts, International Journal of Pharmaceutical Sciences and Research (IJPSR); 5(12) 2021:2174-2181.
  33. Pandey D.K., Kauraw L.P., and Bhan V.M. Inhibitory effect of parthenium (parthenium hysterophorus) residue on growth of water hyacinth (Pontederia crassipes mart solms ) effect of leaf residue, Journal of Chemical Ecology; Vol. 19, No. 11, 1993; 2651-2662.
  34. Sher Wali, Khushnood ur Rehman, Barkat Ullah, Tabassum Yaseen and Gulzad Ahmad, Efficiency of common water hyacinth (Pontederia crassipes) in controlling growth of fungal and bacterial clinical strains, Pure and Applied Biology (PAB); 8(4), 2019: 2178-2186.
  35. P. Jayanthi and P. Lalitha, Antimicrobial activity of solvents extract of Pontederia crassipes (Maer.) solms, Asian Journal of Plant Science and Research; 45 (1): 2011; 13 – 22.
  36. C.J. Rodgers and M.D.  Furones, Anti-microbial agents in aqua culture, 2009; 1-12.
  37. Lata n and V. Dubey, Preliminary phytochemical screening of Pontederia crassipes, Journal of Pharmacy Research, 2010; 11-12.
  38. Wijittra Poonsawat, George Tsaiidis, Christos Tsekos, and Wiebren de Jong, Experimental studies of furfural production from water hyacinth (Pontederia Crassipes, Energy Science & Engineering (Wiley); 2016; 1-10.
  39. Diniatik, Eka Retnowati, Asmiyenti D. Djalil , Molecular Docking Analysis of Volatile Compounds from Fraction of Pontederia crassipes Herbs Ethanol Extract As α-Glucosidase Inhibitor, Indonesian Journal of Pharmaceutical Sciences and Technology (IJPST); 10 (1), 2020; 19-30.
  40. Alexander Patera Nugraha, Amelia Aisyiah Anwar, Aisyah Novianti, NastitiFaradilla Ramadhani, Ratri Maya Sitalaksmi, Muhammad Luthfi, Viol Dhea Kharisma, Rahmad Rifqi Fahreza, Triana Marchelina, Albertus Putera Nugraha, Tengku Natasha Eleena binti Tengku Ahmad Noor, Stigmasterol, Quercetin, and Anthocyanin in Pontederia crassipes as Host Modulation Therapy Candidate: A Bioinformatic Approach, Journal of International Dental and Medical Research; Volume16, 2023; 1067-1073.
  41. Gloria María Molina-Salinas, Jorge Bórquez, Alejandro Ardiles, Salvador Said-Fernández, Luis Alberto Loyola, Aurelio San-Martín, Isidro González-Collado, Antituberculosis activity of natural and semisynthetic azorellane and mulinane diterpenoids, Fitoterapia; Volume 81, Issue 1, 2010; Pages 50-54.
  42. Ryan J. Case, Yuehong Wang, Scott G. Franzblau, D. Doel Soejarto, Lohi Matainaho, Pius Piskaut, Advanced applications of counter-current chromatography in the isolation of anti-tuberculosis constituents from Dracaena angustifolia, Journal of Chromatography; Volume 1151, Issues 1–2, 2007; Pages 169-174.
  43. Juan D. Guzman, Antima Gupta, Dimitrios Evangelopoulos, Chandrakala Basavannacharya, Ludy C. Pabon, Erika A. Plazas, Diego R. Muñoz, Wilman A. Delgado, Luis E. Cuca, Wellman Ribon, Simon Gibbons, Sanjib Bhakta, Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium, Journal of Antimicrobial Chemotherapy; Volume 65, Issue 10, 2010;  Pages 2101–2107.
  44. Khalid A El Sayed, Piotr Bartyzel, Xiaoyu Shen, Tony L Perry, Jordan K Zjawiony, Mark T Hamann, Marine Natural Products as Antituberculosis Agents, Tetrahedron; Volume 56, Issue 7, 2000; 949-953.
  45. Diganta DeyDiganta Dey, Ratnamala Ray, Banasri Hazra, Antitubercular and Antibacterial Activity of Quinonoid Natural Products Against Multi-Drug Resistant Clinical Isolates, Phytotherapy Research;Volume28, Issue7, 2010; 1014-1021.
  46. GuidoF. Pauli, RyanJ, Case, Taichi Inui, Yuehong Wang, Sanghyun Cho, Nikolaus H. Fischer, Scott G. Franzblau, New perspectives on natural products in TB drug research, Life Sciences; Volume 78, Issue 5, 2005; 485-494.
  47. Gautam Kumar, Amrutha C, Natural products and their analogues acting against Mycobacterium tuberculosis: A recent update, Drug Development Research; Volume84, Issue5, 2023; 779-804.
  48. Yuan-Qiang Hu, Zhi Xu, Shu Zhang, Xiang Wu, Jun-Wei Ding, Lian-Shun FengRecent developments of coumarin-containing derivatives and their anti-tubercular activity, European Journal of Medicinal Chemistry; Volume 136, 2017; 122-130.
  49. Navneet Kishore, Bhuwan B. Mishra, Vyasji Tripathi, Vinod K. Tiwari, Alkaloids as potential anti-tubercular agents, Fitoterapia;Volume 80, Issue 3, 2009; 149-163.
  50. Diana Quan, Gayathri Nagalingam, Richard Payne, James A. Triccas, New tuberculosis drug leads from naturally occurring compounds, International Journal of Infectious Diseases;Volume 56, 2007; 212-220.
  51. Ali A. Rabaan, Mohammed Garout, Mohammed Aljeldah, Basim R. Al Shammari, Abdulsalam Alawfi, Amer Alshengeti, Mustafa A. Najim, Mohammed Alrouji, Yasir Almuhanna, Mohammed Alissa, Mutaib M. Mashraqi, Ameen S. S. Alwashmi, Mashael Alhajri, Souad Mohammed Alateah, Ramadan Abdelmoez Farahat &Ranjan K. Mohapatra, Anti-tubercular activity evaluation of natural compounds by targeting Mycobacterium tuberculosis resuscitation promoting factor B inhibition: An in silico study;Volume 28, 2024; 1057–1072.
  52.  Atul Kumar, Suman Srivastava, Garima Gupta, Vinita Chaturvedi, Natural Product Inspired Diversity Oriented Synthesis of Tetrahydroquinoline Scaffolds as Antitubercular Agent, ACS Combinatorial Science; Vol 13/Issue 1, 2020.
  53. Alka Pawar, Prakash Jha, Madhu Chopra, Uma Chaudhry, Daman Saluja, Screening of natural compounds that targets glutamate racemaseof Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids, Scientific Reports; 10, Article number: 949, 2020.
  54. Jidong Zhang, Christine Lair, Christine Roubert, Kwame Amaning, Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents, Cell; Volume 186, Issue 5, 2023; 1013-1025.
  55. Marlene Espinoza-Moraga, Nicholas M, Njuguna, Grace Mugumbate, Julio Caballero, Kelly Chibale, In silico Comparison of Antimycobacterial Natural Products with Known Antituberculosis Drugs, Journal of Chemical Information and Modeling; Vol 53/Issue 3, 2013.
  56. A.Sivakumar and G. Jayaraman, Anti-tuberculosis activity of commonly used medicinal plants of south India, Journal of Medicinal Plants Research; Vol. 5(31), 2011; 6881-6884.
  57. Haggag WM, Abou El Ella SM, Abouziena HF. Phytochemical analysis, antifungal, antimicrobial activities and application of Eichhornia crassipes against some plant pathogens. Planta Daninha. 2017;35:e017163071.
  58. Verma VK, Prakash O, Kumar RSR, Rani KV, Sehgal N. Water hyacinth (Eichhornia crassipes) leaves enhance disease resistance in Channa punctata from Vibrio harveyi infection. Journal of Basic and Applied Zoology. 2021;82(1):1-24.
  59. Chaiwarit T, Chanabodeechalermrung B, Kantrong N, Chittasupho C, Jantrawut P. Fabrication and evaluation of water hyacinth cellulose-composited hydrogel containing quercetin for topical antibacterial applications. Gels. 2022;8(12):767.
  60.  Islami LN, Oktiani BW, Wasiaturrahmah Y. Antibacterial effectiveness of water hyacinth (Eichhornia crassipes) leaf extract on the growth of Porphyromonas gingivalis. Dentin: JurnalKedokteran Gigi. 2023;7(2):63-68.
  61. Ratnani RD, Arianti FD, Sasongko NA. Exploring the potential of water hyacinth weed (Pontederia crassipes) as an environmentally friendly antifungal to realize sustainable development in lakes: A review. Case Studies in Chemical and Environmental Engineering. 2024;9:100702.
  62. Semu TC, Williams J, Cheng J, Mutingwende I, Chifamba J. Pontederia crassipes-biosynthesized silver nanoparticles: Characterization and antimicrobial activity against multidrug-resistant microorganisms. Journal of Advances in Medical and Pharmaceutical Sciences. 2024;26(6):1-16.
  63. El-Gendy AA, El-Banna MM. Eichhornia crassipes (Mart.) Solms: A comprehensive review of its chemical composition, traditional use and value-added products. Frontiers in Pharmacology. 2022;13:842511.
  64. Qin H, Zhang Y, Liu Y, et al. Allelopathic effects of water hyacinth (Eichhornia crassipes) on aquatic plants. PLoS ONE. 2010;5(10):e13200.
  65. Eden WT, Wahyuono S, Cahyono E, Astuti P. Phytochemical screening, antioxidant and cytotoxic activity of water hyacinth (Eichhornia crassipes) ethanolic extract. Tropical Journal of Natural Product Research. 2023;7(8):3606-3612.
  66. Powthong P, Suntornthiticharoen P. Comparative evaluation of antioxidant, antimicrobial and tyrosinase inhibitory activities of Centella asiatica and Eichhornia crassipes. Journal of Medical and Pharmaceutical Allied Sciences. 2023;12:5931-5938.

Photo
D. Abhilasha
Corresponding author

Hindu College of Pharmacy, Gunter, 522002.

Photo
I. Supriya
Co-author

Nirmala College of Pharmacy, Atmakur, 522503.

Photo
S K Insha
Co-author

Hindu College of Pharmacy, Gunter, 522002.

Photo
M. Keerthi
Co-author

Hindu College of Pharmacy, Gunter, 522002.

Photo
G. Hari Krishna
Co-author

Hindu College of Pharmacy, Gunter, 522002.

I. Supriya, S K Insha, M. Keerthi, G. Hari Krishna, D. Abhilasha, Extraction and In-Silico Evaluation of Bioactive Compounds from Pontederia crassipes as Potential Anti-Tubercular Agent, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 8, 1398-1428. https://doi.org/10.5281/zenodo.21840457